JM Thurman, RW Schrier - The American journal of medicine, 2003 - Elsevier
Many clinicians are uncomfortable about using angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptorblockers (AT 1 -blockers) to treat patients with renal …
… II receptorblockers are as effective as angiotensin-converting enzymeinhibitors on the risk … Angiotensin II receptorblockers may be slightly more protective than angiotensin-converting …
CA Dézsi - American Journal of Cardiovascular Drugs, 2014 - Springer
… Although both angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor antagonists (angiotensin receptorblockers; ARBs) are equally important in the treatment of …
… are mediated through stimulation of angiotensin II receptor 1. Angiotensin receptorblockers (ARBs) prevent angiotensin II receptor 1 stimulation without direct effects on bradykinin/…
TWR Doulton, FJ He, GA MacGregor - Hypertension, 2005 - Am Heart Assoc
… receptorblocker on blood pressure. Proteinuria was reduced by the combination compared with ACE inhibitor and angiotensin receptorblocker … inhibitor-angiotensin receptorblocker …
Objectives : This study was designed to identify all randomized clinical trial data evaluating angiotensin-converting enzymeinhibitors or angiotensin receptorblockers for the prevention …
… with hypertension is confounded by treatment with specific antihypertensive medications: angiotensin-converting enzymeinhibitors (ACEIs) and angiotensin receptorblockers (ARBs). …
M Böhm - The American journal of cardiology, 2007 - Elsevier
… This article reviews the effects of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptorblockers (ARBs) at different stages of the cardiovascular continuum: …
… Beta‐blocker (BB) drugs, angiotensin‐converting enzymeinhibitors (ACEi) and angiotensin receptorblockers (ARB) were suggested to have a favorable role in the development and …